Nuveen’s Opko Health OPK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.29M | Buy |
863,035
+16,042
| +2% | +$20.5K | ﹤0.01% | 2807 |
|
|
2026
Q1 | $966K | Buy |
846,993
+5,157
| +0.6% | +$6.35K | ﹤0.01% | 2594 |
|
|
2025
Q4 | $1.06M | Hold |
841,836
| – | – | ﹤0.01% | 2592 |
|
|
2025
Q3 | $1.3M | Sell |
841,836
-284,721
| -25% | -$391K | ﹤0.01% | 2494 |
|
|
2025
Q2 | $1.49M | Sell |
1,126,557
-250,324
| -18% | -$342K | ﹤0.01% | 2429 |
|
|
2025
Q1 | $2.29M | Sell |
1,376,881
-55,523
| -4% | -$91.4K | ﹤0.01% | 2288 |
|
|
2024
Q4 | $2.11M | Buy |
1,432,404
+425,484
| +42% | +$650K | ﹤0.01% | 2365 |
|
|
2024
Q3 | $1.5M | Sell |
1,006,920
-42,717
| -4% | -$63.4K | ﹤0.01% | 2566 |
|
|
2024
Q2 | $1.31M | Hold |
1,049,637
| – | – | ﹤0.01% | 2593 |
|
|
2024
Q1 | $1.26M | Sell |
1,049,637
-97,732
| -9% | -$97.8K | ﹤0.01% | 2600 |
|
|
2023
Q4 | $1.73M | Sell |
1,147,369
-1,517,045
| -57% | -$2.19M | ﹤0.01% | 2474 |
|
|
2023
Q3 | $4.26M | Sell |
2,664,414
-13,761
| -0.5% | -$25.1K | ﹤0.01% | 1944 |
|
|
2023
Q2 | $5.81M | Hold |
2,678,175
| – | – | ﹤0.01% | 1833 |
|
|
2023
Q1 | $3.91M | Buy |
2,678,175
+237,111
| +10% | +$305K | ﹤0.01% | 2026 |
|
|
2022
Q4 | $3.05M | Buy |
2,441,064
+239,428
| +11% | +$377K | ﹤0.01% | 2190 |
|
|
2022
Q3 | $4.16M | Sell |
2,201,636
-483,570
| -18% | -$1.14M | ﹤0.01% | 2007 |
|
|
2022
Q2 | $6.79M | Sell |
2,685,206
-808,276
| -23% | -$2.36M | ﹤0.01% | 1749 |
|
|
2022
Q1 | $12.5M | Buy |
3,493,482
+1,272
| +0% | +$4.49K | ﹤0.01% | 1505 |
|
|
2021
Q4 | $16.8M | Buy |
3,492,210
+656,465
| +23% | +$2.66M | 0.01% | 1334 |
|
|
2021
Q3 | $10.3M | Sell |
2,835,745
-515,132
| -15% | -$1.92M | ﹤0.01% | 1759 |
|
|
2021
Q2 | $13.6M | Buy |
3,350,877
+402,853
| +14% | +$1.58M | ﹤0.01% | 1665 |
|
|
2021
Q1 | $12.6M | Sell |
2,948,024
-45,567
| -2% | -$218K | ﹤0.01% | 1647 |
|
|
2020
Q4 | $11.8M | Sell |
2,993,591
-592,003
| -17% | -$2.47M | ﹤0.01% | 1594 |
|
|
2020
Q3 | $13.2M | Sell |
3,585,594
-60,585
| -2% | -$256K | 0.01% | 1332 |
|
|
2020
Q2 | $12.4M | Buy |
3,646,179
+284,200
| +8% | +$637K | 0.01% | 1342 |
|
|
2020
Q1 | $4.5M | Buy |
3,361,979
+946,135
| +39% | +$1.48M | ﹤0.01% | 1770 |
|
|
2019
Q4 | $3.55M | Buy |
2,415,844
+347,719
| +17% | +$582K | ﹤0.01% | 2160 |
|
|
2019
Q3 | $4.32M | Buy |
2,068,125
+105,538
| +5% | +$216K | ﹤0.01% | 2038 |
|
|
2019
Q2 | $4.79M | Buy |
+1,962,587
| New | +$4.28M | ﹤0.01% | 2017 |
|
|
2015
Q2 | – | Sell |
-15,283
| Closed | -$217K | – | 1631 |
|
|
2015
Q1 | $217K | Hold |
15,283
| – | – | ﹤0.01% | 1504 |
|
|
2014
Q4 | $153K | Sell |
15,283
-450
| -3% | -$3.85K | ﹤0.01% | 1550 |
|
|
2014
Q3 | $134K | Hold |
15,733
| – | – | ﹤0.01% | 1527 |
|
|
2014
Q2 | $139K | Hold |
15,733
| – | – | ﹤0.01% | 1537 |
|
|
2014
Q1 | $147K | Hold |
15,733
| – | – | ﹤0.01% | 1524 |
|
|
2013
Q4 | $133K | Buy |
15,733
+3,080
| +24% | +$31.1K | ﹤0.01% | 1510 |
|
|
2013
Q3 | $111K | Buy |
12,653
+2,410
| +24% | +$19.3K | ﹤0.01% | 1427 |
|
|
2013
Q2 | $73K | Buy |
+10,243
| New | +$70.7K | ﹤0.01% | 1496 |
|
Other funds holding OPK
RCMNY
WCM
Nuveen's OPK Position: Q2 2026 in Review
Nuveen increased its Opko Health (OPK) stake by 1.9% in Q2 2026, buying an estimated $20.5K and bringing the position to 863,035 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #2807.
Nuveen first reported a position in OPK in Q2 2013 and has held it in 37 quarters since. The position peaked at $16.8M in Q4 2021. 223 funds tracked by Wall St. Rank hold OPK as of Q2 2026.
- Nuveen held 863,035 shares of Opko Health worth $1.29M as of Q2 2026.
- Nuveen bought 16,042 Opko Health shares in Q2 2026, an estimated $20.5K.
- Opko Health made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2807 holding.
- Nuveen first reported a position in Opko Health in Q2 2013 and has held it in 37 quarters since.
- Nuveen's Opko Health position peaked at $16.8M in Q4 2021.
- 223 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.